|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Rapid Communication |
1 Centre for Stem Cell Biology & Developmental Genetics and Institute of Human Genetics
2 School of Biological and Biomedical Sciences, University of Durham
3 Newcastle Fertility Centre at Life, International Centre for Life
* To whom correspondence should be addressed. E-mail: majlinda.lako{at}ncl.ac.uk.
| Abstract |
|---|
The homeobox transcription factor Nanog has been proposed to play a crucial role in the maintenance of the undifferentiated state of murine embryonic stem cells. A human counterpart, NANOG, has been identified but its function and localisation has not hitherto been described. We have used a combination of RNA interference and quantitative real-time PCR to study NANOG in human embryonic stem and embryonic carcinoma cells. Transfection of NANOG-specific short interfering RNAs reduced levels of NANOG transcript and protein and induced activation of the extraembryonic endoderm-associated genes GATA4, GATA6, LAMININ B1 and AFP as well as upregulation of trophectoderm-associated genes CDX2, GATA2, hCG-alpha and hCG-beta. Immunostaining of preimplantation human embryos showed that NANOG was expressed in the inner cell mass of expanded blastocysts but not in earlier stage embryos consistent with a role in the maintenance of pluripotency. Taken together our findings suggest that NANOG acts as a gatekeeper of pluripotency in human embryonic stem and carcinoma cells by preventing their differentiation to extraembryonic endoderm and trophectoderm lineages.
Key Words. NANOG, human embryonic stem cells, pluripotency, siRNA, trophectoderm, primitive endoderm
This article has been cited by other articles:
![]() |
G. Cauffman, M. De Rycke, K. Sermon, I. Liebaers, and H. Van de Velde Markers that define stemness in ESC are unable to identify the totipotent cells in human preimplantation embryos Hum. Reprod., January 1, 2009; 24(1): 63 - 70. [Abstract] [Full Text] [PDF] |
||||
![]() |
B.V. Johnson, N. Shindo, P.D. Rathjen, J. Rathjen, and R.A. Keough Understanding pluripotency--how embryonic stem cells keep their options open Mol. Hum. Reprod., September 1, 2008; 14(9): 513 - 520. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Yu and J. A. Thomson Pluripotent stem cell lines Genes & Dev., August 1, 2008; 22(15): 1987 - 1997. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Van de Velde, G. Cauffman, H. Tournaye, P. Devroey, and I. Liebaers The four blastomeres of a 4-cell stage human embryo are able to develop individually into blastocysts with inner cell mass and trophectoderm Hum. Reprod., August 1, 2008; 23(8): 1742 - 1747. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Fong, K. A. Hohenstein, and P. J. Donovan Regulation of Self-Renewal and Pluripotency by Sox2 in Human Embryonic Stem Cells Stem Cells, August 1, 2008; 26(8): 1931 - 1938. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Monk, M. Hitchins, and S. Hawes Differential expression of the embryo/cancer gene ECSA(DPPA2), the cancer/testis gene BORIS and the pluripotency structural gene OCT4, in human preimplantation development Mol. Hum. Reprod., June 1, 2008; 14(6): 347 - 355. [Abstract] [Full Text] [PDF] |
||||
![]() |
U. Ullmann, C. Gilles, M. De Rycke, H. Van de Velde, K. Sermon, and I. Liebaers GSK-3-specific inhibitor-supplemented hESC medium prevents the epithelial-mesenchymal transition process and the up-regulation of matrix metalloproteinases in hESCs cultured in feeder-free conditions Mol. Hum. Reprod., March 1, 2008; 14(3): 169 - 179. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Choudhary, X. Zhang, P. Stojkovic, L. Hyslop, G. Anyfantis, M. Herbert, A. P. Murdoch, M. Stojkovic, and M. Lako Putative Role of Hyaluronan and Its Related Genes, HAS2 and RHAMM, in Human Early Preimplantation Embryogenesis and Embryonic Stem Cell Characterization Stem Cells, December 1, 2007; 25(12): 3045 - 3057. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. S. Lim, Y.-H. Loh, W. Zhang, Y. Li, X. Chen, Y. Wang, M. Bakre, H.-H. Ng, and L. W. Stanton Zic3 Is Required for Maintenance of Pluripotency in Embryonic Stem Cells Mol. Biol. Cell, April 1, 2007; 18(4): 1348 - 1358. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Qin, T. Yu, T. Qing, Y. Liu, Y. Zhao, J. Cai, J. Li, Z. Song, X. Qu, P. Zhou, et al. Regulation of Apoptosis and Differentiation by p53 in Human Embryonic Stem Cells J. Biol. Chem., February 23, 2007; 282(8): 5842 - 5852. [Abstract] [Full Text] [PDF] |
||||
![]() |
U. Ullmann, P. In't Veld, C. Gilles, K. Sermon, M. De Rycke, H. Van de Velde, A. Van Steirteghem, and I. Liebaers Epithelial-mesenchymal transition process in human embryonic stem cells cultured in feeder-free conditions Mol. Hum. Reprod., January 1, 2007; 13(1): 21 - 32. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. N. Brimble, E. S. Sherrer, E. W. Uhl, E. Wang, S. Kelly, A. H. Merrill Jr., A. J. Robins, and T. C. Schulz The Cell Surface Glycosphingolipids SSEA-3 and SSEA-4 Are Not Essential for Human ESC Pluripotency Stem Cells, January 1, 2007; 25(1): 54 - 62. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Cauffman, I. Liebaers, A. Van Steirteghem, and H. Van de Velde POU5F1 Isoforms Show Different Expression Patterns in Human Embryonic Stem Cells and Preimplantation Embryos Stem Cells, December 1, 2006; 24(12): 2685 - 2691. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Hasegawa, T. Fujioka, Y. Nakamura, N. Nakatsuji, and H. Suemori A Method for the Selection of Human Embryonic Stem Cell Sublines with High Replating Efficiency After Single-Cell Dissociation Stem Cells, December 1, 2006; 24(12): 2649 - 2660. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Zhang, P. Stojkovic, S. Przyborski, M. Cooke, L. Armstrong, M. Lako, and M. Stojkovic Derivation of Human Embryonic Stem Cells from Developing and Arrested Embryos Stem Cells, December 1, 2006; 24(12): 2669 - 2676. [Abstract] [Full Text] [PDF] |
||||
![]() |
S.-y. Yasuda, N. Tsuneyoshi, T. Sumi, K. Hasegawa, T. Tada, N. Nakatsuji, and H. Suemori NANOG maintains self-renewal of primate ES cells in the absence of a feeder layer. Genes Cells, September 1, 2006; 11(9): 1115 - 1123. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Armstrong, O. Hughes, S. Yung, L. Hyslop, R. Stewart, I. Wappler, H. Peters, T. Walter, P. Stojkovic, J. Evans, et al. The role of PI3K/AKT, MAPK/ERK and NF{kappa}{beta} signalling in the maintenance of human embryonic stem cell pluripotency and viability highlighted by transcriptional profiling and functional analysis Hum. Mol. Genet., June 1, 2006; 15(11): 1894 - 1913. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. R. Hough, I. Clements, P. J. Welch, and K. A. Wiederholt Differentiation of Mouse Embryonic Stem Cells after RNA Interference-Mediated Silencing of OCT4 and Nanog Stem Cells, June 1, 2006; 24(6): 1467 - 1475. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Nganvongpanit, H. Muller, F. Rings, M. Hoelker, D. Jennen, E. Tholen, V. Havlicek, U. Besenfelder, K. Schellander, and D. Tesfaye Selective degradation of maternal and embryonic transcripts in in vitro produced bovine oocytes and embryos using sequence specific double-stranded RNA. Reproduction, May 1, 2006; 131(5): 861 - 874. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| STEM CELLS | THE ONCOLOGIST | CME | ALPHAMED PRESS JOURNALS |
